Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2014  |  Volume : 10  |  Issue : 5  |  Page : 52-55

Aidi injection combined with FOLFOX4 chemotherapy regimen in the treatment of advanced colorectal carcinoma


1 Department of Colorectal Surgery, Tianjin Union Medicine Center; Tianjin University of Traditional Chinese Medicine, Tianjin, China
2 Department of Geriatrics, Tianjin Medical University General Hospital, Tianjin Geriatrics Institute, Tianjin, China
3 Department of Colorectal Surgery, Tianjin Union Medicine Center, Tianjin, China
4 Department of Colorectal Surgery, Anorectal Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China
5 Department of Gastrointestinal Thyroid Surgery, the First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang Uygur Autonomous Region, China

Correspondence Address:
Mulati
Department of Gastrointestinal Thyroid Surgery, the First Affiliated Hospital of Shihezi University, Shihezi, 832000 China. Shibei 2 Road, Shihezi City, Xinjiang Uygur Autonomous Region, Shihezi, P.R.C 832000
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.139760

Rights and Permissions

Objective: The aim of this retrospectively study was to evaluate the clinical efficacy of Aidi injection (ADI) combined with FOLFOX4 chemothreapy regimen in the treatment of advanced colorectal carcinoma. Patients and Methods: One hundred and twenty one patients with pathology confirmed advanced colorectal carcinoma were retrospectively analyzed in the department of colorectal surgery in Union Medical Center, Tianjin (UMC). Of the included 121 cases, 58 subjects received the treatment of ADI combined with FOLFOX4 chemotherapy (experiment group) and the other 63 cases received the FOLFOX4 chemotherapy alone (control group). After two cycles chemotherapy treatment, the short-term clinical efficacy such as complete response (CR), partial response (PR) and objective response rate (ORR) were compared between the two groups. The quality of life improvement and chemotherapy related toxicity were also recorded and analyzed. Results: The response rate including CR, PR and ORR were not statistical different between the experiment group and control group (P > 0.05); The KPS score was significant decrease in the control group compared to that in experiment group (P < 0.05); The risk of developing grade-II nausea vomiting and diarrhea was much lower in experiment than that in control group (Pall < 0.05). Conclusion: ADI combined with FOLFOX4 chemotherapy can improve the quality of life and decrease some of the toxicity related to chemotherapy in patients with advanced colorectal cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1712    
    Printed35    
    Emailed0    
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal